Curapharma SRL
Curapharma reported total assets of 352,271 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 May 2026).
The score of Curapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +33 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Curapharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 7,040 € | ||||
| Equity | 134,902 € | ||||
| Cash | 60,745 € | ||||
| EBITDA | 17,027 € | ||||
| Total assets | 352,271 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 May 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 09 Jun 2023
- Year ended 31 Dec 2021filed on 02 Jun 2022
Curapharma's financial analysis
- Solvency38.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Curapharma
Curapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0878.122.786
- VAT number
- BE0878122786
- Peppol
- Registered · 0208:0878122786 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Dec 2005
- Registered office
- 1930 Zaventem
- Latest accounts
- 2025 · filed on 28 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Curapharma (SRL) has been based in Zaventem since 2005, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 7,040 € and equity of 134,902 €; its revenue is not published. Its solvency stands at 38.3%, below the median of its sector (44.2%).
Companies similar to Curapharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Stroombank Retail sale of pharmaceutical products Ostend · balance sheet 333,286 €
- Pharmaq Retail sale of pharmaceutical products Mons · balance sheet 375,271 €
- I & CM Marbotin Retail sale of pharmaceutical products Schaerbeek · balance sheet 323,588 €
- Pharmacie Derasse Retail sale of pharmaceutical products La Louvière · balance sheet 387,571 €
- Paracelsus Retail sale of pharmaceutical products Aalst · balance sheet 413,042 €
- Melbuj Retail sale of pharmaceutical products Wemmel · balance sheet 237,909 €
- Farma Booischot Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 558,918 €
- Pharma Leyens Retail sale of pharmaceutical products Liège · balance sheet 311,356 €
Frequently asked questions about Curapharma
What is the revenue of Curapharma?
Curapharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Curapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0878122786 for Curapharma, if the company is VAT-registered. Its company number (CBE) is 0878.122.786.
Where is the registered office of Curapharma?
According to the CBE register, the registered office of Curapharma is in 1930 Zaventem.
What is the equity of Curapharma?
At the close of the 2025 financial year, the equity of Curapharma amounts to 134,902 €, a solvency of 38.3% of total assets.
Who manages Curapharma?
The register lists 2 active mandates at Curapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Curapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →